Although incidence of sudden cardiac death in hypertrophic cardiomyopathy (HCM) has improved over the last 10 years, there has been no improvement in incidence of heart failure and no targeted therapies to reduce incidence of HF in HCM. We review CMR predictors of HF in HCM, in particular the role of myocardial replacement fibrosis and myocardial perfusion assessment
Article will review the current state of knowledge of HF in HCM and present recently published data using CMR to assess predictors of HF in HCM.
To close the gap outlined above, learners will need:
- To review the incidence of heart failure in HCM
- To review CMR predictors of heart failure in HCM
- To understand the limitations of the data presente
The Society for Cardiovascular Magnetic Resonance (SCMR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
The Society for Cardiovascular Magnetic Resonance (SCMR) designates this Journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Instructions for Claiming CME
- Read and fully comprehend the article
- Complete the post-activity evaluation
- A certificate of completion will be available once the evaluation is submitted
The planners and faculty for this activity did not have any relationships to disclose unless listed below: None
Disclosure of Commercial Support
This activity received no commercial support.
Please see the bibliography at the end of the journal article.